Antirotinib Hydrochloride Plus Whole Brain Radiotherapy for Small Cell Lung Cancer With Brain Metastases
Clinical trial NCT06611657 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06611657
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-20
- Primary completion
- 2024-06-10
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.